Steven Cohen’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$368K Buy
+82,917
New +$372K ﹤0.01% 3249
2026
Q1
– Sell
-169,792
Closed -$416K – 4501
2025
Q4
$416K Buy
+169,792
New +$737K ﹤0.01% 3329
2025
Q1
– Sell
-190,100
Closed -$1.41M – 2533
2024
Q4
$1.41M Buy
+190,100
New +$1.27M ﹤0.01% 1374
2024
Q3
– Sell
-362,710
Closed -$2.41M – 2346
2024
Q2
$2.41M Buy
+362,710
New +$2.93M 0.01% 1044
2023
Q4
– Sell
-1,252,628
Closed -$16.4M – 2821
2023
Q3
$16.4M Sell
1,252,628
-165,916
-12% -$3.04M 0.05% 465
2023
Q2
$36.3M Buy
1,418,544
+1,065,992
+302% +$27.5M 0.11% 237
2023
Q1
$8.88M Sell
352,552
-43,154
-11% -$1.01M 0.03% 576
2022
Q4
$9.1M Buy
395,706
+100,275
+34% +$2.31M 0.03% 583
2022
Q3
$6.52M Buy
295,431
+75,236
+34% +$1.46M 0.03% 634
2022
Q2
$3.16M Buy
220,195
+8,435
+4% +$142K 0.01% 820
2022
Q1
$4M Buy
211,760
+177,410
+516% +$3.45M 0.02% 751
2021
Q4
$640K Buy
+34,350
New +$709K ﹤0.01% 952

Other funds holding TMCI

Steven Cohen's TMCI Position: Q3 2026 in Review

Steven Cohen opened a new position in Treace Medical Concepts (TMCI) in Q3 2026: 82,917 shares worth $368K. The stake represents ﹤0.01% of the portfolio and ranks #3249 among its holdings. This is a return to the name: Steven Cohen previously reported a position in TMCI as recently as Q4 2025.

Steven Cohen first reported a position in TMCI in Q4 2021 and has held it in 12 quarters since. The position peaked at $36.3M in Q2 2023. 116 funds tracked by Wall St. Rank hold TMCI as of Q3 2026.

  • Steven Cohen held 82,917 shares of Treace Medical Concepts worth $368K as of Q3 2026.
  • Treace Medical Concepts was a new Steven Cohen position in Q3 2026.
  • Treace Medical Concepts made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3249 holding.
  • Steven Cohen first reported a position in Treace Medical Concepts in Q4 2021 and has held it in 12 quarters since.
  • Steven Cohen's Treace Medical Concepts position peaked at $36.3M in Q2 2023.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.